ERGOLINE-1,8-DICARBOXAMIDE, N8-(3-(DIMETHYLAMINO)PROPYL)-N1-ETHYL-N8-((ETHYLAMINO)CARBONYL)-6-(2-PROPENYL)-, (8.BETA.)-
UNII 5A8SL691O4
Substance Identification & Data
This profile provides standardized clinical and technical data for Ergoline-1,8-dicarboxamide, N8-(3-(dimethylamino)propyl)-n1-ethyl-n8-((ethylamino)carbonyl)-6-(2-propenyl)-, (8.beta.)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 5A8SL691O4.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 126554-50-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C29H42N6O3 MNAGYQBVKIBCGP-GZGNHOFSSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for Ergoline-1,8-dicarboxamide, N8-(3-(dimethylamino)propyl)-n1-ethyl-n8-((ethylamino)carbonyl)-6-(2-propenyl)-, (8.beta.)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.